Company Analysis

MeiraGTx Holdings plc (MGTX)

Nasdaq: MGTX · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2018
Grade6.2
◀ Past 7.1● Present 5.9▶ Future 5.7
2 est.

Filings

236 filings since 2017 beside 276 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
5764464064516682
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Sep 23, 2026.SEC letters: 2 in the last 36 months, the newest Dec 27, 2023.
Insider forms 276

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 S-3ASR Shelf registration
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 23, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Sep 22, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 S-8 Employee stock plan registration
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 7, 2026 8-K items 1.01, 1.02, 2.03, 3.02, 7.01, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jun 30, 2026
Jun 15, 2026 8-K item 5.07 Shareholder vote · Current report Jun 11, 2026
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
May 13, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEF 14A Proxy statement Jun 11, 2026
Apr 24, 2026 SCHEDULE 13D/A Activist holder update, amended
Apr 24, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Apr 20, 2026
Apr 16, 2026 424B5 Shelf offering
Apr 16, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Apr 16, 2026 8-K items 1.01, 1.02, 2.01, 7.01, 8.01, 9.01 Major agreement signed; Major agreement ended; Purchase or sale of a business completed; Investor disclosure (Regulation FD); Other event · Current report Apr 15, 2026
Apr 16, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 1.01, 2.02, 2.03, 9.01 Major agreement signed; Results released; New debt or obligation taken on · Current report Mar 25, 2026
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 SCHEDULE 13G Large holder notice
Jan 2, 2026 SCHEDULE 13D/A Activist holder update, amended
Jan 2, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Dec 31, 2025
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Nov 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 13, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 10, 2025 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Nov 7, 2025
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Aug 14, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 26, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Jun 17, 2025 8-K item 5.07 Shareholder vote · Current report Jun 12, 2025
May 14, 2025 SCHEDULE 13G/A Large holder update, amended
May 13, 2025 10-Q Quarterly report Mar 31, 2025
May 13, 2025 8-K items 2.02, 9.01 Results released · Current report
May 9, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
40 of 236 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MGTX · research, not advice